<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03929224</url>
  </required_header>
  <id_info>
    <org_study_id>1325595</org_study_id>
    <nct_id>NCT03929224</nct_id>
  </id_info>
  <brief_title>The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown</brief_title>
  <official_title>The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ascension South East Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ascension South East Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative medicinal grade honey in addition to standard post-operative care may prevent
      bone anchored hearing aid associated skin breakdown better than standard care alone in adult
      patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective study. Multiple surgeons will perform the bone anchored hearing aids
      (BAHA) implantation surgery. Patients will be randomized to either postoperative medicinal
      honey and standard care or postoperative standard care alone using a random number generator.
      There will be a total of two patient groups. The type of BAHA device used, laterally and the
      surgical technique will be recorded.

      Treatment groups:

      Group 1-patients undergoing BAHA implantation who will be postoperatively treated with
      medicinal honey and standard care.

      Group 2- patients undergoing BAHA implantation who will be postoperatively treated with
      standard care.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 25, 2018</start_date>
  <completion_date type="Anticipated">September 3, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 3, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of MediHoney application on the surgical site</measure>
    <time_frame>The surgical site will be graded 1-week post-op.</time_frame>
    <description>The surgical site will be graded based on the Holger Classification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of MediHoney application on the surgical site</measure>
    <time_frame>The surgical site will be graded 1-month post-op.</time_frame>
    <description>The surgical site will be graded based on the Holger Classification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of MediHoney application on the surgical site</measure>
    <time_frame>The surgical site will be graded 3-months post-op.</time_frame>
    <description>The surgical site will be graded based on the Holger Classification.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of MediHoney application on the surgical site</measure>
    <time_frame>The surgical site will be graded 6-months post-op.</time_frame>
    <description>The surgical site will be graded based on the Holger Classification.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Skin Infection</condition>
  <arm_group>
    <arm_group_label>Bacitracin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard care: BAHA abutment incision is coated in bacitracin. A healing cap is placed over the abutment and left for a week. The healing cap is removed on postoperative day 7. Patient is instructed to apply bacitracin ointment to the area for 2 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medicinal honey and bacitracin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard care + MediHoney: Medi-Honey will be applied to the abutment site immediately after surgery in addition to the bacitracin. The healing cap will be placed on the BAHA site. The healing cap is removed on postoperative day 7. Patient is instructed to apply bacitracin ointment and MediHoney daily to the area for 2 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medicinal honey and bacitracin</intervention_name>
    <description>Treat healing surgical site with medicinal honey and bacitracin</description>
    <arm_group_label>Medicinal honey and bacitracin</arm_group_label>
    <other_name>MediHoney</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bacitracin</intervention_name>
    <description>Treat healing surgical site with bacitracin</description>
    <arm_group_label>Bacitracin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing bone-anchored hearing aid implantation surgery.

        Exclusion Criteria:

          -  patients who are undergoing revision bone-anchored hearing surgery, history of
             radiation to the implantation site.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seilesh Babu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan Ear Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seilesh Babu, MD</last_name>
    <phone>(248) 865-4444</phone>
    <email>sbabu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marianne Lahey, BSN</last_name>
    <phone>(248) 465-4828</phone>
    <email>Marianne.Lahey@ascension.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ascension Providence Hospital, Novi Campus</name>
      <address>
        <city>Novi</city>
        <state>Michigan</state>
        <zip>48374</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seilish Babu, MD</last_name>
      <phone>248-865-4444</phone>
      <email>sbabu@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Seilish Babu, MD</last_name>
      <phone>(248) 865-4444</phone>
      <email>sbabu@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Costeloe A, Vandjelovic ND, Evans MA, Saraiya SS. The use of honey in cochlear implant associated wounds in pediatric patients. Int J Pediatr Otorhinolaryngol. 2018 Aug;111:80-83. doi: 10.1016/j.ijporl.2018.05.026. Epub 2018 May 24.</citation>
    <PMID>29958620</PMID>
  </reference>
  <reference>
    <citation>Faucett EA, Reghunathan S, Jacob A. Medicinal honey as treatment for skin reactions associated with bone-anchored hearing implant surgery. Laryngoscope. 2015 Jul;125(7):1720-3. doi: 10.1002/lary.25069. Epub 2014 Dec 4.</citation>
    <PMID>25476170</PMID>
  </reference>
  <reference>
    <citation>Bento RF, Kiesewetter A, Ikari LS, Brito R. Bone-anchored hearing aid (BAHA): indications, functional results, and comparison with reconstructive surgery of the ear. Int Arch Otorhinolaryngol. 2012 Jul;16(3):400-5. doi: 10.7162/S1809-97772012000300017. Review.</citation>
    <PMID>25991965</PMID>
  </reference>
  <reference>
    <citation>Colquitt JL, Jones J, Harris P, Loveman E, Bird A, Clegg AJ, Baguley DM, Proops DW, Mitchell TE, Sheehan PZ, Welch K. Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation. Health Technol Assess. 2011 Jul;15(26):1-200, iii-iv. doi: 10.3310/hta15260. Review.</citation>
    <PMID>21729632</PMID>
  </reference>
  <reference>
    <citation>Fontaine N, Hemar P, Schultz P, Charpiot A, Debry C. BAHA implant: implantation technique and complications. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Feb;131(1):69-74. doi: 10.1016/j.anorl.2012.10.006. Epub 2013 Jul 5.</citation>
    <PMID>23835074</PMID>
  </reference>
  <reference>
    <citation>Robson V, Dodd S, Thomas S. Standardized antibacterial honey (Medihoney) with standard therapy in wound care: randomized clinical trial. J Adv Nurs. 2009 Mar;65(3):565-75. doi: 10.1111/j.1365-2648.2008.04923.x.</citation>
    <PMID>19222654</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2019</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cellulitis</mesh_term>
    <mesh_term>Skin Diseases, Infectious</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacitracin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

